Full Text View
Tabular View
No Study Results Posted
Related Studies
Organ Preservation Media Investigation
This study has been completed.
First Received: September 13, 2005   Last Updated: June 5, 2008   History of Changes
Sponsor: University of Wisconsin, Madison
Information provided by: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00225472
  Purpose

Kidney transplantation remains limited by four problems: 1) a too high rate of delayed graft function, 2) early loss of kidneys from chronic rejection, 3) donor kidney shortages, and 4) the need for immunomodulating treatments. Improved cold storage methods can significantly impact on the first 3 of these 4 major problems. The device to be tested is a modification of the existing Viaspan organ preservation solution. The modification of this solution combines four compounds: Bovine neutrophil peptide-1 (BNP-1), Substance P (SP), Insulin-like growth factor-1 (IGF-1), and Nerve Growth Factor (NGF). This solution will be added to Viaspan for preservation of donor kidneys. Preclinical data indicates that trophic factor deprivation during cold storage is a significant and previously unrecognized mechanism of injury in cold stored kidneys. The aim of this study is improved graft function, decreasing early graft loss due to rejection, and decreasing the donor organ shortage.


Condition Intervention Phase
Kidney Transplant
Device: Modified Viaspan
Phase I

Study Type: Interventional
Study Design: Non-Randomized, Open Label, Active Control, Single Group Assignment
Official Title: Organ Preservation Media Investigation

Resource links provided by NLM:


Further study details as provided by University of Wisconsin, Madison:

Estimated Enrollment: 20
Study Start Date: June 2004
Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • first renal transplant, PRA's <20%

Exclusion Criteria:

  • PRA's greater than 20%
  • Subjects who are receiving a non-primary renal transplant
  • Subjects under the age of 18
  • Pregnant or nursing women
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00225472

Locations
United States, Wisconsin
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Anthony Dalessandro, MD University of Wisconsin Medical School
  More Information

No publications provided

Study ID Numbers: 2002-566
Study First Received: September 13, 2005
Last Updated: June 5, 2008
ClinicalTrials.gov Identifier: NCT00225472     History of Changes
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on November 22, 2009